Weekly Industry News – Pharma & Healthcare

Pharma & Healthcare – the latest on CVS’s False Claims allegations, accusations of insularity haunt the Teva board and more.


CVS Caremark Pays $4.25 Million to Settle False Claims Allegations by Akin Gump Strauss Hauer & Feld LLP Published on jdsupra.com

Earlier this month, Caremark Incorporated – a drug benefit management company operated by drug retail giant CVS Caremark Corporation –agreed to pay $4.25 million to settle allegations that it knowingly failed to reimburse Medicaid, Tricare, and other governmental health care programs, for prescription drug costs paid on behalf of beneficiaries who were also covered by private insurance companies administered by Caremark… [ Read More ]

Accusations of insularity and interference haunt the Teva board by Andrew Jack Published on ft.com

Even by the standards of the regular leaks of sensitive corporate material from Teva, images on Israeli television last October showed a letter from senior management to its directors was still explosive… [ Read More ]  

Justice Department Announces $3.8 Billion In False Claims Act Recoveries In FY 2013 by Lauren Slive Published on jdsupra.com

On December 20, 2013, the Justice Department announced a total of $3.8 billion dollars in settlements and judgments from civil cases involving the False Claims Act for Fiscal Year (FY) 2013. Total recoveries under the False Claims Act since January 2009 have reached $17 billion… [ Read More ]

Live  Industry News

  Twitter    Follow @ACI_Pharma  and @ACI_Health LinkedIn-Logo-2C (1)   Join ACI Pharmaceuticals/Biotech/Life Sciences Experts Group Join ACI Healthcare: Legal, Regulatory, and Compliance Experts Group  

Related Events

False Claims and Qui Tam EnforcementPatent Reform

For the complete list of all Pharma upcoming events: Click Here

For the complete list of all Healthcare upcoming events: Click Here

To download past Pharma conference materials: Click Here

To download past Healthcare conference materials: Click Here